Categories: News

RenalytixAI to Present at the 39th Annual J.P. Morgan Healthcare Conference

NEW YORK, Jan. 04, 2021 (GLOBE NEWSWIRE) — Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today announced the company will be presenting at the upcoming 39th Annual J.P. Morgan Virtual Healthcare Conference.

RenalytixAI’s management is scheduled to present on Wednesday, January 13 at 10:00 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at investors.renalytixai.com.

About RenalytixAI
RenalytixAI is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI’s products are being designed to make significant improvements in kidney disease diagnosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery. For more information, visit www.renalytixai.com.

Disclosure Information
Renalytix AI plc uses filings with the Securities and Exchange Commission, its website (www.renalytixai.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Investor Contact:
investors@renalytixai.com

Staff

Recent Posts

Numinus Clarifies Disclosures

Vancouver, British Columbia--(Newsfile Corp. - June 7, 2024) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX:…

3 hours ago

Woodfords Family Services Media Notice of Information Security Incident

WESTBROOK, ME / ACCESSWIRE / June 7, 2024 / What Happened?We discovered unauthorized access on…

4 hours ago

cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards

Charlotte, North Carolina--(Newsfile Corp. - June 7, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

7 hours ago

Monotype Joins The Readability Consortium to Advance Global Readability Research

ORLANDO, Fla., June 7, 2024 /PRNewswire/ -- Monotype, one of the most recognized names in…

7 hours ago

FINDHELP CEO Erine Gray Advocates for Data-Driven Solutions to Fix the Social Safety Net

WASHINGTON, June 7, 2024 /PRNewswire/ -- Erine Gray, CEO of findhelp, a leading social services technology…

7 hours ago